Racing medication and testing consortium
Download
1 / 33

RACING MEDICATION AND TESTING CONSORTIUM - PowerPoint PPT Presentation


  • 313 Views
  • Updated On :

RACING MEDICATION AND TESTING CONSORTIUM. Dan Fick The Jockey Club Executive Director & Executive Vice President. Topics. Mission Uniform Model Rules Research Anabolic Steroids Drug Testing Funding. Mission of RMTC.

Related searches for RACING MEDICATION AND TESTING CONSORTIUM

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'RACING MEDICATION AND TESTING CONSORTIUM' - oshin


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Racing medication and testing consortium l.jpg

RACING MEDICATION AND TESTING CONSORTIUM

Dan Fick

The Jockey Club

Executive Director

& Executive Vice President


Topics l.jpg
Topics

  • Mission

  • Uniform Model Rules

  • Research

  • Anabolic Steroids

  • Drug Testing

  • Funding


Mission of rmtc l.jpg
Mission of RMTC

  • To develop, promote and coordinate, at the national level, policies, research and educational programs that seek to:

    • ensure fairness and integrity of racing

    • ensure the health and welfare of racehorses and participants

    • protect the interests of the racing public

  • RMTC was formed in 2002 as a 501 (c)(3) charitable organization; donations are tax deductible.


Board of directors l.jpg

AAEP

AQHA

Arabian Jockey Club

Breeders’ Cup

California TB Trainers

Churchill Downs

Del Mar

Hambletonian Society

Harness Tracks of America

Jockey Club     

Jockeys’ Guild

Keeneland

Kentucky TB Association

Magna Entertainment

National HBPA

NTRA

NYRA

Oak Tree

RCI

THA

TOBA

TB Owners of California

TRA

TRPB

USTA

Board of Directors


Rmtc officers l.jpg
RMTC Officers

  • Executive Director: Dr. Scot Waterman

  • Chairman: Dr. Bobby Lewis - AAEP

  • Vice Chairman: Chris Scherf - TRA

  • Vice Chairman: Alan Foreman - THA

  • Secretary: Dr. Rick Arthur - CHRB

  • Treasurer: Tom Charters - Hambletonian

  • CEO: Dan Fick - The Jockey Club


Rmtc model of operation l.jpg
RMTC Model of Operation

  • Goals:

    • Uniform regulation

    • Level playing field

    • Welfare and safety of participants

  • Implementation Strategy:

    • Review existing research

    • New research

    • Scientific Advisory Committee

    • Consensus of directors


Model rules phase 1 2005 l.jpg
Model Rules Phase 1 (2005)

  • Veterinary Practices

  • Prohibited Practices

  • Drug Classifications/Categorization

  • Permitted Therapeutics:

    • Race Day

      • Voluntary use of Lasix

      • Adjuncts permitted pending research

      • Anti-ulcer medications

    • One of three NSAID – Bute, Banamine & Ketoprofen – 24 hours


Slide8 l.jpg

Language adopted

Language in the process of being adopted

Process require significant legislative action

Process has not been started

No horse racing or harness racing commission

Model Rules


Uniform penalties 2006 l.jpg
Uniform Penalties (2006)

  • Three-tiered grid system simplified existing RCI penalties

  • Significantly increases penalties for illegal and prohibited performance-enhancing drugs

  • Reduces penalties for therapeutic medication mistakes

  • Redefines trainer responsibility

    • Mitigating and aggravating circumstances “checklist” for stewards

    • Added penalties for other culpable licensees: veterinarians, owners and grooms

  • Adopted as rule or policy in 25 states


Uniform model penalties policy l.jpg
Uniform Model Penalties Policy

  • Class A – Illegal, not approved, significant performance enhancement

    Lifetime:

    • 1st Offense – Minimum 1 year & $ 10,000 Maximum 3 year & $ 25,000

    • 3rd Offense – Minimum 5 year & $ 50,000 Maximum 10 year & $100,000

  • Class C – Therapeutic medications at less than performance enhancing levels

    365 Days

    • 1st Offense – Minimum $ 500

    • 2nd Offense – Minimum 15 day & $ 1,000

    • 3rd Offense – Minimum 30 day & $ 2,500


Slide11 l.jpg

New RCI Model Rules

  • Regulation of anabolic steroids

    • Limited to four FDA-permitted anabolics

      • Stanozolol (Winstrol)

      • Boldenone (Equipoise)

      • Nandrolone

      • Testosterone

    • 30-45 days withdrawal time

  • Out-of-competition testing

    • Blood-doping agents – EPO & Darbypoietin

    • Illegal & prohibited drugs


Research l.jpg
Research

  • Research grants - $965,000 to date

    • Performance enhancers

      • Erythropoietin, Ethanol and Cone Snail Venom

    • Therapeutics

      • Procaine Penicillin, Flunixin, Clenbuterol and Amicar

    • Environmental contaminants

      • Morphine and Cocaine

    • Research on 50 therapeutics and anabolic steroids

    • Unknowns from backstretch contacts

  • 25-horse research training stable

  • Dr. Don Catlin – Anti-Doping Research Lab


Rmtc research program l.jpg
RMTC Research Program

  • RMTC is also focused on developing tests for “designer” drugs

  • “Unknown” acquisition and analysis:

    • RMTC works with sources and purchases products being marketed as “performance enhancing”

    • Over a dozen vials and syringes have been analyzed over the past two years

    • Majority contain “voodoo” products and are of little concern

    • In 2007, one unknown led to a federal investigation and prosecution of a “race-day medication” website


Withdrawal times research l.jpg
Withdrawal Times Research

  • Identified drugs with legitimate uses

  • Prioritized drugs into five groups

  • Collected previous science on each drug

  • If science is insufficient then perform administrations on a minimum of 20 horses

  • Research costs of administration, collection and analysis are $20,000 up to $40,000 depending on drug

  • Plasma is preferred but some drugs will have both urine and plasma collected

  • Ultimate goal: uniform withdrawal time with a corresponding threshold level of drug which regulates the withdrawal time


Withdrawal times research16 l.jpg

Priority Group 1

Acepromazine

Butorphanol

Detomidine

Glycopyrrolate

Lidocaine

Mepivacaine

Methocarbamol

Pyrilamine

Priority Group 2

Boldenone

Dantrolene

Dexamethasone

Fluphenazine

Hydroxyzine

Nandrolone

Stanozolol

Testosterone

Withdrawal Times Research


Withdrawal times research17 l.jpg

Priority Group 3

Albuterol

Betamethasone

Diclofenac

Methylprednisolone

Reserpine

Triamcinolone

Trichlormethiazide

Xylazine

Priority Group 4

Atropine

Beclomethasone

Buscopan

Cromolyn

Isoxsuprine

Pentoxyfylline

Phenytoin

Prednisolone

Withdrawal Times Research


Withdrawal times research18 l.jpg

Priority Group 5

Diazepam

Dipyrone

Fluorprednisolone

Guaifenesin

Isoflupredone

Prednisone

Research finished

Aminocaproic Acid

Carbazochrome

Clenbuterol

Procaine Penicillin

Cimetidine

DMSO

Flunixin

Furosemide

Ketoprofen

Omeprazole

Phenylbutazone

Ranitidine

Withdrawal Times Research


Withdrawal time database l.jpg
Withdrawal Time Database

  • Withdrawal times posted for 18 jurisdictions and over 70 drugs

  • Database is searchable by drug and by jurisdiction

  • Over 2,000 unique users in first month of availability

  • Help us add more (New Mexico)

  • www.rmtcnet.com, click on “Withdrawal Times” tab at top of page


Slide20 l.jpg

Scot

Waterman


Anabolic steroids l.jpg
Anabolic steroids

  • Why now?

    • Several surveys showed extremely high levels of use

    • Perception and level of public consciousness of anabolic steroids

    • Federal scrutiny of major league sports

    • Legislation to ban steroids introduced in Congress

    • Harmonizes the U.S. internationally


Anabolic steroids26 l.jpg
Anabolic steroids

  • Model rule approved by RCI in April 2007

  • Revised by RCI in December 2007 to cover the intact male

  • Model rule contains urinary thresholds for 4 anabolic steroids that are permitted by FDA

  • Plasma thresholds will be added once administration studies are completed this fall


Anabolic steroids27 l.jpg
Anabolic Steroids

  • AR, AZ, CO, DE, IA, IL, IN, PA, VA, WA have adopted this model rule

  • At least 12 other states have started the adoption process

  • RMTC & RCI have encouraged every state to be done with the adoption process by 12/31

  • Recommendations for implementation approved by RMTC & RCI in March 2008


Anabolic steroids28 l.jpg
Anabolic Steroids

  • RMTC Board recommends:

    • 90-day grace period on penalty enforcement when rule is introduced

    • Notification to owner/trainer for overage,

    • No fine or loss of purse absent aggravating circumstances

    • After 90 days, jurisdictions should follow the penalty guidelines in the model rules $500 and loss of purse for 1st violation

    • Pre-entry testing must be made available in some form


Anabolic steroids29 l.jpg
Anabolic Steroids

  • RMTC Board recommends:

    • Boldenone, stanozolol, nandrolone and testosterone should not be administered within 30 days of a race

    • If needed outside of 30 days, must be documented by veterinarian, must include diagnosis and filed with the regulatory body

    • Horse should then test negative before being allowed to enter.

    • Claimed horses may be tested on request and at the cost of the claimant. If positive, claim can be voided and cost of testing borne by original owner.


Anabolic steroids30 l.jpg
Anabolic Steroids

  • Significant interest at the federal level on this issue

  • Reps from RMTC, RCI, NTRA met with congressional staffers in Jan ‘08

  • Alex Waldrop recently testified in front of House Energy and Commerce Sub-committee

  • Interstate Horseracing Act is in play, state regulation of drug control also in jeopardy

  • Congressmen Whitfield & Rush drafting legislation with possible hearing in mid-June.


Drug testing objectives l.jpg
Drug Testing Objectives

  • Uniform Testing

    • Standards for chain of custody, split and frozen samples

    • Standard operating procedures and testing protocols

    • Quality assurance and blind sampling

    • Laboratory accreditation

  • Future Considerations

    • National industry-owned reference laboratory

    • Potential for consolidation of 18 existing drug-testing laboratories


Funding l.jpg
Funding

  • $2.7 million bridge financing from industry organizations 2003-2006

  • 2007 Contributions = $683,126

  • 2008 Projected Funding:

    • $1 per start from horsemen and racetracks

    • $700,000 from industry organizations

    • $500,000 research and testing grants fromThe Jockey Club & Kentucky Horse Racing Authority

    • Tax-deductible donations from individuals


Rmtc contact us l.jpg
RMTC: Contact Us

  • www.rmtcnet.com